搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 30 天
时间不限
过去 1 小时
过去 24 小时
过去 7 天
按时间排序
按相关度排序
Lifehacker
2 小时
The FDA Is Finally Pulling a Useless Cold Medicine From the Market
Phenylephrine is also supposed to be able to constrict blood vessels to relieve congestion, but studies show it breaks down ...
4 小时
Lemsip and other cold and flu decongestants are ‘not effective’ as experts call for ...
LEMSIP and other popular cold and flu tablets should be pulled from Britain’s shelves because they don’t work, experts have ...
Las Vegas Review-Journal
5 小时
FDA proposes pulling decongestants from shelves over ingredient
Also, this is a proposed order, so you can still buy the medication if you want. Only a final order will affect what products ...
6 小时
Ban Lemsip because 'it doesn't work', say experts after US health chiefs propose pulling ...
Yesterday, US health officials proposed getting rid of oral drugs containing the decongestant phenylephrine over concerns ...
abc7NY
9 小时
FDA moves to pull nasal decongestant in some cold medicines from shelves amid effectiveness ...
The US Food and Drug Administration announced a proposal to remove oral phenylephrine - a common ingredient in many popular ...
Atlanta Journal-Constitution
10 小时
FDA wants to halt sales of decongestants containing ineffective phenylephrine
Also, this is a proposed order, so you can still buy the medication if you want. Only a final order will affect what products can be marketed. Among the products containing oral phenylephrine as an ...
来自MSN
14 小时
These Over-The-Counter Decongestants Don't Work, FDA Says
Oral phenylephrine, widely marketed in cold and allergy medications, has been in use for decades as a go-to nasal ...
The Financial Express
18 小时
USFDA proposes removal of common decongestant from shelves after finding it ineffective
The FDA would provide manufacturers with appropriate time to either reformulate drugs containing oral phenylephrine or remove ...
18 小时
TEZSPIRE MET BOTH CO-PRIMARY ENDPOINTS IN PHASE 3 TRIAL FOR CHRONIC RHINOSINUSITIS WITH ...
Amgen (NASDAQ:AMGN) and AstraZeneca today announced positive top-line results from the Phase 3 WAYPOINT trial in patients ...
23 小时
FDA Recommends Removing Ingredient From Many Cold and Allergy Medicines After Research ...
Cold and flu season is upon us and Americans will be flocking to pharmacy shelves to pick up some medicine to alleviate their ...
1 天
FDA moves to pull popular decongestant from shelves amid effectiveness concerns
The FDA announced a proposal to remove oral phenylephrine – a common ingredient in many popular over-the-counter ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈